Rev1 is Essential for DNA Damage Tolerance and Non-templated Immunoglobulin Gene Mutation in a Vertebrate Cell Line
Overview
Molecular Biology
Authors
Affiliations
The majority of DNA damage-induced mutagenesis in the yeast Saccharomyces cerevisiae arises as a result of translesion replication. This process is critically dependent on the deoxycytidyl transferase Rev1p, which forms a complex with the subunits of DNA polymerase zeta, Rev3p and Rev7p. To examine the role of Rev1 in vertebrate mutagenesis and the DNA damage response, we disrupted the gene in DT40 cells. Rev1-deficient DT40 grow slowly and are sensitive to a wide range of DNA-damaging agents. Homologous recombination repair is likely to be intact as basal and damage induced sister chromatid exchange and immunoglobulin gene conversion are unaffected. How ever, the mutant cells show a markedly reduced level of non-templated immunoglobulin gene mutation, indicating a defect in translesion bypass. Furthermore, ultraviolet exposure results in marked chromosome breakage, suggesting that replication gaps created in the absence of Rev1 cannot be efficiently repaired by recombination. Thus, Rev1-dependent translesion bypass and mutagenesis is likely to be a trade-off for the ability to complete replication of a damaged template and thereby maintain genome integrity.
FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions.
Alcon P, Kaczmarczyk A, Ray K, Liolios T, Guilbaud G, Sijacki T Nature. 2024; 632(8027):1165-1173.
PMID: 39085614 PMC: 11358013. DOI: 10.1038/s41586-024-07770-w.
Primordial germ cell DNA demethylation and development require DNA translesion synthesis.
Shah P, Hill R, Dion C, Clark S, Abakir A, Willems J Nat Commun. 2024; 15(1):3734.
PMID: 38702312 PMC: 11068800. DOI: 10.1038/s41467-024-47219-2.
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer.
Taylor S, Arends M, Langdon S Explor Target Antitumor Ther. 2022; 1(1):26-52.
PMID: 36046263 PMC: 9400734. DOI: 10.37349/etat.2020.00003.
Mechanisms of APOBEC3 mutagenesis in human cancer cells.
Petljak M, Dananberg A, Chu K, Bergstrom E, Striepen J, von Morgen P Nature. 2022; 607(7920):799-807.
PMID: 35859169 PMC: 9329121. DOI: 10.1038/s41586-022-04972-y.
Chen D, Gervai J, Poti A, Nemeth E, Szeltner Z, Szikriszt B Nat Commun. 2022; 13(1):226.
PMID: 35017534 PMC: 8752635. DOI: 10.1038/s41467-021-27872-7.